Literature DB >> 12003689

The role of a pharmacist in ambulatory cancer pain management.

Anna Ratka1.   

Abstract

Cancer pain is progressive and complex. The multidimensional character of cancer pain requires comprehensive management by a multidisciplinary team of health care professionals. Pharmacotherapy is a cornerstone of cancer pain management. Pharmacists who are engaged in ambulatory cancer pain management can play a pivotal role in the pharmacotherapy of cancer pain by optimizing medication therapy, monitoring outcomes, enhancing adherence through patient education regarding drug use, pain and symptom control, educating other health professionals and students, and conducting research. To fully meet the therapeutic challenges of cancer pain, pharmacists need to improve their knowledge and attitudes about cancer pain and pain medications.

Entities:  

Mesh:

Year:  2002        PMID: 12003689     DOI: 10.1007/s11916-002-0034-5

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  13 in total

Review 1.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

2.  Computerized quality-of-life screening in a cancer pain clinic.

Authors:  L E Carlson; M Speca; N Hagen; P Taenzer
Journal:  J Palliat Care       Date:  2001       Impact factor: 2.250

3.  Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial.

Authors:  S L Du Pen; A R Du Pen; N Polissar; J Hansberry; B M Kraybill; M Stillman; J Panke; R Everly; K Syrjala
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

4.  Multidisciplinary symptom control clinic in a cancer center: a retrospective study.

Authors:  E Bruera; M Michaud; A Vigano; C M Neumann; S Watanabe; J Hanson
Journal:  Support Care Cancer       Date:  2001-05       Impact factor: 3.603

5.  Pharmacists' knowledge of and attitudes toward opioid pain medications in relation to federal and state policies.

Authors:  D E Joranson; A M Gilson
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Mar-Apr

6.  Pharmacy-perceived barriers to cancer pain control: results of the North Carolina Cancer Pain Initiative Pharmacist Survey.

Authors:  S E Krick; C M Lindley; M Bennett
Journal:  Ann Pharmacother       Date:  1994 Jul-Aug       Impact factor: 3.154

7.  Pain, opioid use, and survival in hospitalized patients with advanced cancer.

Authors:  F J Brescia; R K Portenoy; M Ryan; L Krasnoff; G Gray
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

8.  Multicentre study of cancer pain and its treatment in France.

Authors:  F Larue; S M Colleau; L Brasseur; C S Cleeland
Journal:  BMJ       Date:  1995-04-22

9.  Pain in far-advanced cancer.

Authors:  Robert G Twycross; Sarah Fairfield
Journal:  Pain       Date:  1982-11       Impact factor: 6.961

Review 10.  Breakthrough pain: definition and management.

Authors:  R K Portenoy; N A Hagen
Journal:  Oncology (Williston Park)       Date:  1989-08       Impact factor: 2.990

View more
  2 in total

Review 1.  The pharmacist's role in managing chronic opioid therapy.

Authors:  J Mark Wallace
Journal:  Curr Pain Headache Rep       Date:  2006-08

2.  Knowledge, attitudes, and practices toward cancer pain management amongst healthcare workers (physicians, pharmacists, and nurses): a cross-sectional study from first-tier cities in China.

Authors:  Jiyi Xie; Cong Zhang; Shijun Li; Rong Dai; Bin Deng; Qiling Xu; Jinglin Wang; Chen Shi; Yu Zhang
Journal:  Support Care Cancer       Date:  2022-05-20       Impact factor: 3.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.